Equivalent outcomes using reduced intensity or conventional...

E-mail: regis.peffaultdelatour@sls.aphp.fr Allogeneic hematopoietic stem cell transplantation provides the best chance of long-term survival for patients with AML, but is associated with an unpredictable risk of treatment-related mortality. From January 2000 to December 2010, we compared the outcomes for patients with AML aged 35 and over using reduced-intensity conditioning transplantation.

http://ift.tt/1KlZKCz